Yahoo
ASX - Delayed Quote AUD

Artrya Limited (AYA.AX)

2.7700 +0.0400 (+1.47%)
At close: October 30 at 4:10:11 PM GMT+11
Chart Range Bar
Loading chart for AYA.AX
  • Previous Close 2.7300
  • Open 2.7000
  • Bid 2.7600 x --
  • Ask 2.8500 x --
  • Day's Range 2.7000 - 2.8800
  • 52 Week Range 1.9950 - 6.4900
  • Volume 996,694
  • Avg. Volume 1,401,523
  • Market Cap (intraday) 454.394M
  • Beta (5Y Monthly) 0.65
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1700
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 5.40

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. It offers Salix, a suite of cloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. The company was incorporated in 2018 and is based in West Perth, Australia.

www.artrya.com

--

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

AYA.AX
41.19%
S&P/ASX 200 [XJO] (^AXJO)
2.22%

1-Year Return

AYA.AX
18.77%
S&P/ASX 200 [XJO] (^AXJO)
0.29%

3-Year Return

AYA.AX
1,159.09%
S&P/ASX 200 [XJO] (^AXJO)
31.37%

5-Year Return

AYA.AX
91.03%
S&P/ASX 200 [XJO] (^AXJO)
21.63%

Analyst Insights

View More

Analyst Price Targets

4.25
5.40 Average
2.7700 Current
7.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 10/30/2026
  • Market Cap

    454.39M

  • Enterprise Value

    380.47M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (current)

    --

  • Price/Sales (ttm)

    6.49k

  • Price/Book (mrq)

    5.77

  • Enterprise Value/Revenue

    13.59k

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -31.64%

  • Return on Equity (ttm)

    -50.58%

  • Revenue (ttm)

    28k

  • Net Income Avi to Common (ttm)

    -25.18M

  • Diluted EPS (ttm)

    -0.1700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    74.03M

  • Total Debt/Equity (mrq)

    0.32%

  • Levered Free Cash Flow (ttm)

    -11.94M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: